The Drugs Controller General of India Has Granted Approval to Sanofi & Glaxo Smith ... - Latest Tweet by IANS Tweets

The Drugs Controller General of India has granted approval to Sanofi & Glaxo Smith Kline to conduct Phase-III clinical study, to assess the safety, efficacy & immunogenicity of their adjuvanted recombinant-protein #Covid19 vaccine candidate in India, the pharma giants announced. pic.twitter.com/q1V6BzzUTX— IANS Tweets (@ians_india) July 8, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)